Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study

OBJECTIVE: Tumor necrosis factor inhibitors (TNFi) are an effective treatment for non‐radiographic axial spondyloarthritis (nr‐axSpA). To be eligible, however, many authorities require patients with nr‐axSpA to show active sacroiliitis on magnetic resonance imaging (MRI) and/or an elevated C‐reactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Philip C., Maksymowych, Walter P., Gensler, Lianne S., Hall, Stephen, Rudwaleit, Martin, Hoepken, Bengt, Bauer, Lars, Kumke, Thomas, Kim, Mindy, de Peyrecave, Natasha, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469479/
https://www.ncbi.nlm.nih.gov/pubmed/35733363
http://dx.doi.org/10.1002/acr2.11469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469479/
https://www.ncbi.nlm.nih.gov/pubmed/35733363
http://dx.doi.org/10.1002/acr2.11469

Ejemplares similares